Problem

Increasing drug experimentation in developing countries

Nature:

Introduction of experimental pharmaceuticals into less developed countries where public health regulations are not restrictive, is an increasing phenomenon.

Incidence:

Trials of new contraceptive drugs, for example, are often conducted in Third World countries which may have no preclinical requirements or supervision for therapeutic testing; pharmaceutical companies may wish to evade controls imposed for the safety of women's health in such trials. Drug companies in the USA, for example, spend between 15 and 20% of their research budgets abroad, mainly in developing countries, for all kinds of products.

Values:
Increase
Related UN Sustainable Development Goals:
GOAL 3: Good Health and Well-beingGOAL 11: Sustainable Cities and Communities
Problem Type:
E: Emanations of other problems
Date of last update
16.09.2019 – 17:07 CEST